🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multimodal Program for Climacteric Women

RecruitingNAAges 45 Years - 85 YearsFemaleUniversity of Valencia
NCT06419972 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Your study seems to aim at emphasizing the significance of non-pharmacological and non-hormonal approaches in managing menopausal symptoms, particularly focusing on muscle training and education. This holistic approach acknowledges the importance of physical well-being, psychological support, and education to enhance women's quality of life during the menopausal transition.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women aged ≥45 years * Women in climacteric period Exclusion Criteria: * Musculoskeletal, cognitive, infectious, neurological, or cardiorespiratory pathology impairing assessment or program completion. * Surgical intervention in lumbopelvic or gynecological region within the last 6 months. Undergoing oncological treatment. \* Also included women with stable hormone replacement therapy for at least the last 6 months.
💊

What it tests

  • multimodal physiotherapy programme
📍

Where

2 sites
Department of Physiotherapy. University of Valencia
Valencia, Spain
Laura Fuentes Aparicio
Valencia, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy